UM51 cells treated with the study compound at 10 µM for 72 h showed a highly significant reduction in the ratio of KI67-positive cells to total cell number compared with untreated cells (p < 0.001). Whole organ cultures of utricles from male and female CBA/J mice received compound pretreatment followed by immediate RNA extraction, with vehicle-only utricles as controls. Significant and considerable induction of the measured readout was reported. In MTFs, immunoblot analysis performed 48 hours after compound treatment showed increased protein expression compared with the DMSO control. [1,2,3]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Reduced KI67 Positivity in UM51 Cells
Cell-based study · UM51 cells [1]
UM51 cells treated with the study compound at 10 µM for 72 h showed a highly significant reduction in the ratio of KI67-positive cells to total cell number compared with untreated cells (p < 0.001).
Literature-Reported Treatment Conditions
- Treatment concentration
- 10 µM
- Exposure duration
- 72 h
- Co-treatment
- Other interventions in this design: bFGF 5 ng/mL. Compound effect isolated by the comparison: with and without JNK inhibition at 72 h.
- Reported limits
- Not stated in the sentences used: route, vehicle.
Methods and source locations
Compound reported in the paper: AEG 3482
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
2. Materials and Methods > 2.1. Cell Culture (S3, S4, S8, S9, S10); 2. Materials and Methods > 2.3. Proliferation Assay (S19, S21); 2. Materials and Methods > 2.7. Flow Cytometry-Based Measurement of Lipid Peroxidation (S40); 3. Results > 3.2. JNK Inhibition Leads to Decreased Proliferation and Loss of Progenitor State (S109, S111, S113)
ratio of KI67-positive/total cell number: ratio of KI67-positive/total cell number; comparator: untreated cells — 2. Materials and Methods > 2.3. Proliferation Assay (S21); 3. Results > 3.2. JNK Inhibition Leads to Decreased Proliferation and Loss of Progenitor State (S113)
Compound Pretreatment in Mouse Utricle Cultures
Cell-based study · utricles from both male and female CBA/J mice (age 4–8 weeks) [2]
Whole organ cultures of utricles from male and female CBA/J mice received compound pretreatment followed by immediate RNA extraction, with vehicle-only utricles as controls. Significant and considerable induction of the measured readout was reported.
Literature-Reported Treatment Conditions
- Treatment concentration
- 25 μM
- Exposure duration
- 6-h pre-treatment followed by immediate RNA extraction
- Method
- whole organ cultures of utricles from adult mice
- Vehicle
- 0.1% DMSO
Methods and source locations
Compound reported in the paper: AEG 3482
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Organotypic Utricle Explant Culture (S7); Materials and Methods > RT-qPCR Expression (S41); Results > LINCS Hits Induce the Heat Shock Transcriptional Expression Signature in Cultured Mouse Utricles (S142, S144, S147, S152); FIGURE 6 legend (S227)
Hmox1 induction: Hmox1 induction; comparator: control utricles treated only with the 0.1% DMSO vehicle — Results > LINCS Hits Induce the Heat Shock Transcriptional Expression Signature in Cultured Mouse Utricles (S152)
Increased Protein Expression Following Compound Treatment in MTFs
Cell-based study · MTFs [3]
In MTFs, immunoblot analysis performed 48 hours after compound treatment showed increased protein expression compared with the DMSO control.
Literature-Reported Treatment Conditions
- Exposure duration
- 48 hours after compound treatment
- Vehicle
- DMSO
- Reported limits
- Not stated in the sentences used: dose, route.
Methods and source locations
Compound reported in the paper: AEG 3482
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
RESULTS > Transcriptomic analysis reveals that AEG3482 and cardamonin induce Nrf2 target genes (S158, S159); MATERIALS AND METHODS > Immunoblotting (S223); Fig. 5 legend (S280)
immunoblot analysis for GCLC (Glutamate-Cysteine Ligase Catalytic Subunit) and GCLM (Glutamate-Cysteine Ligase Modifier Subunit) (subunits of glutamate cysteine ligase, involved in the glutathione synthesis pathway Fig. 5D), and Hmox1: immunoblot analysis for GCLC (Glutamate-Cysteine Ligase Catalytic Subunit) and GCLM (Glutamate-Cysteine Ligase Modifier Subunit) (subunits of glutamate cysteine ligase, involved in the glutathione synthesis pathway Fig. 5D), and Hmox1; comparator: DMSO — RESULTS > Transcriptomic analysis reveals that AEG3482 and cardamonin induce Nrf2 target genes (S158, S159)